Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.
about
What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal StudiesReal-time PCR in clinical microbiology: applications for routine laboratory testing.[102 patients with suspected myocarditis : Clinical presentation, diagnostics, therapy and prognosis].Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.Parvovirus B19 infection after transplantation: a review of 98 cases.Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles.Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patientsMolecular and clinicopathological findings in a tonsillar synovial sarcoma. A case study and review of the literatureGreen fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification.Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure.Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patientsHuman parvovirus B19: a mechanistic overview of infection and DNA replication.Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells.The Impact of Specific Viruses on Clinical Outcome in Children Presenting with Acute Heart Failure.Fatal parvoviral myocarditis: a case report and review of literature.Myocarditis mimicking acute coronary syndrome following influenza B virus infection: a case report.A Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19.Reviewing peripartum cardiomyopathy: current state of knowledge.Molecular phenotypes of human parvovirus B19 in patients with myocarditis.The management of myocarditis.Parvovirus B19 myocarditis causes significant morbidity and mortality in children.Viral myocarditis: from experimental models to molecular diagnosis in patients.Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease.Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing.Viral endomyocardial infection in the 1st year post transplant is associated with persistent inflammation in children who have undergone cardiac transplant.Viral myocarditis--diagnosis, treatment options, and current controversies.The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature.Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.Human Parvoviruses.Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy.Outcome predictors in dilated cardiomyopathy or myocarditis.Sudden death of an immunocompetent young adult caused by novel (swine origin) influenza A/H1N1-associated myocarditis.Clinical profile of patients with advanced age and inflammatoric dilated cardiomyopathy on endomyocardial biopsy.The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.
P2860
Q26738973-ECE5D377-EF0C-4F0E-8839-1B35F49FA775Q27472851-3FF74ABC-9DB9-4D98-8105-A62EBBF8CF29Q30313532-C741E8FC-7BB8-4F2B-8CEB-642086E85DC7Q30318661-19FC7DCE-94D0-4542-BB26-5857D28658B5Q33371465-246338A9-8292-408A-9220-16FE52CC2034Q33712962-9AF2CAA6-E5C5-4C7B-A7B3-658D01A876ADQ33900233-7D6222D6-876E-45C7-8A9D-D6D0611DACAFQ33987551-48CA50FB-7ECB-4D83-9FE7-BA735B3C6574Q34072080-195FBA91-BFDA-4478-9FA6-0F4C882E55BFQ34206352-F0EA02E5-34CB-4004-8915-C54EE0B6E874Q34618009-A2E32977-026D-4EA5-8886-B5E8828AC47BQ34941558-46B90A7D-C13C-4F88-9ADB-E273C99C3B98Q35751511-3FCF73D7-D0ED-4ACA-B86F-339A3C2F007EQ36148725-8C31601B-EF73-4AAB-AAE9-75EDB844FBDDQ36326300-3F20E3EE-80EF-4627-ABFB-25D92984A6F6Q36845694-61F0D168-DB7C-42C9-B04F-5C99F9EE1D16Q36846996-7F4FAD97-7BBA-47EB-8A7F-05E48901F908Q37151419-7F4AEDAC-4B16-4A01-AC5A-00AAD7BA908EQ37338315-CF28FCA4-087B-42E8-938B-AB7415C9C556Q37366530-A829699D-8B78-44B9-A3B2-ADA1F7D4715EQ37445871-AEC9FD1D-D7EB-4892-8D23-FE2CAF2B86A5Q37722777-2130DBAF-EE47-4BA0-BC29-337A7E160190Q37894482-2B04053C-494E-4E51-A4C9-5B8EB36D5F59Q38032733-F5761261-1199-43E6-8407-81E00CD35A03Q38052447-3B3C1EBB-BA87-4736-8BDF-A43E30AF79E7Q38055369-616609C8-0A8C-45BC-A292-C9C59107F153Q38088715-ACE17716-35FC-41E7-ACFC-40ED4C19883AQ38107322-6E3F4A85-6D87-47D5-BC4B-2EA3A099659CQ38551013-3E0639CF-FDD9-47F9-A2DC-80471AC4B3D9Q38661867-077D7D61-B718-487F-8FF3-9CCC3D421B7CQ38810914-5D850785-A20B-4F46-97BA-FEB454FEFF47Q38895571-49F18124-EAD9-4BD2-AE5C-3A82F916F2B1Q38996997-1B8E7EE1-FBF1-4844-9958-554CB9CBB537Q39305479-80E481B2-03C9-4B3B-A540-2C69FAE3F984Q39326024-E41096BB-1E82-4818-B069-D432C5099C3FQ39718255-EA68B55F-68AF-4DBB-8FC6-012EA6512D04Q40181302-75E16A55-751C-402A-8D2B-DF884E29C6AAQ40337318-DD75C9E3-430F-4D1C-9B4E-07FF3CDD09FBQ40963982-2F2FD0D5-71B8-4E77-9419-D931B645DB7FQ42221396-AA7D01F9-C487-4ADB-B444-67374CCB83B9
P2860
Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@en
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@nl
type
label
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@en
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@nl
prefLabel
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@en
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@nl
P2093
P356
P1433
P1476
Fatal parvovirus B19-associate ...... thelial cell-mediated disease.
@en
P2093
Burkhard D Bültmann
Hideo A Baba
Karin Klingel
Karl Sotlar
Martina Sauter
P356
10.1053/HUPA.2003.48
P407
P577
2003-01-01T00:00:00Z